Startup data
| Business model | |
|---|---|
| Country | |
| Investment Received | |
| Revenues | |
| Scope | |
| Startup stage | |
| Tecnhologies | |
| Verticals |
Sensible Biotechnologies
€0,00
Video-Pitch: https://youtu.be/joarCGJWkuY
Description: Two-sentence description The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA therapeutics and vaccines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way. Vision At Sensible Bio, we strive to unlock the full potential of mRNA and its clinical applications. We are doing this by creating a novel, cell-based platform for the cost-efficient and scalable manufacturing of high-quality mRNA. Sensible Bio will become an integral part of the global bio-manufacturing infrastructure and biosecurity framework and a critical supplier enabling the advent of many future applications of mRNA.
